Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents : Determined Using the BSRBR-AS and a MetaAnalysis
Publication date
02/2023Metadata
Show full item recordCitation
Macfarlane , G , Biallas , R , Dean , LE , Jones , GT , Goodson , N J & Rotariu , O 2023 , ' Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents : Determined Using the BSRBR-AS and a MetaAnalysis ' , Journal of Rheumatology , vol. 50 , no. 2 , pp. 175-184 . https://doi.org/10.3899/jrheum.211034